Home
/
Treatment
/
(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one

(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one

	(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one
Trade Name
Orphan Indication	Hodgkin’s disease
USA Market Approval	USA
USA Designation Date	2015-04-29 00:00:00
Sponsor	Incyte Corporation;1801 Augustine Cut-Off;Wilmington, Delaware, 19803

Related Access Program

AbbVie – Non-Hodgkin’s Lymphoma Seattle Genetics, Inc. – Lymphoma, Non-Hodgkin Molecular Templates, Inc. – Non-Hodgkin’s B-cell Lymphoma